Arrowhead Pharmaceuticals Funding & Investors

Pasadena, CA

Arrowhead Pharmaceuticals, Inc. operates as a biotechnology company. The Company develops medicines that treat intractable diseases by silencing the genes. Arrowhead Pharmaceuticals offers its services in the United States.

arrowheadpharma.com

Total Amount Raised: $1,624,882,944

Arrowhead Pharmaceuticals Funding Rounds

Post Ipo Equity
$325,000,000
Nov 25, 2024
Post Ipo Equity Investors
Sarepta Therapeutics
Post Ipo Debt
$400,000,000
Aug 7, 2024
Post Ipo Debt Investors
Sixth Street
Post Ipo Equity
$450,000,000
Jan 2, 2024
Post Ipo Equity
$266,800,000
Dec 5, 2019
Post Ipo Equity
$9,600,000
Jan 9, 2017
Post Ipo Equity Investors
Silence Therapeutics
Post Ipo Equity
$45,000,000
Aug 15, 2016
Post Ipo Equity Investors
OrbiMed Advisors
Post Ipo Equity
$60,000,000
Oct 13, 2013
Post Ipo Equity Investors
RA Capital Management
Post Ipo Equity
$36,000,000
May 5, 2013
Post Ipo Equity
$3,222,896
Jan 28, 2010
Post Ipo Equity
$3,222,896
Jan 28, 2010
Post Ipo Equity
$2,760,000
Aug 12, 2009
Post Ipo Equity
$2,760,000
Aug 12, 2009
Post Ipo Equity
$16,500,000
May 20, 2007
Post Ipo Equity Investors
York Capital Management
Post Ipo Equity
$10,000,000
Oct 25, 2006
IPO
Unknown
Jan 1, 1995

Funding info provided by Diffbot.